Pfizer has said it is waiting for regulatory approval of its vaccine from the US drug Regulators to Children aged 12 to 15.
“Pending regulatory decision, we hope to make this vaccine available to the 12-15-year-old age group before the start of the 2021 school year,” Pfizer said.
Last week, Pfizer had announced that its vaccine was seen 100% effective in teens between the age of 12 to 16.
Pfizer has said it will be seeking approvals from regulators across the world. “We plan to request similar rulings by other regulatory authorities worldwide in the coming days,” the company said.
Pfizer claims that there have been fewer side effects among teens than in adults.
The company has also begun trials on children below 11. The trials of efficacy are being done on children as young as six months,